Mission Pharmacal offers Urocit-K (potassium citrate), 5 mEq and 10 mEqtablets, for the management of renal tubular acidosis with calcium stones,hypocitraturic calcium oxalate nephrolithiasis of any etiology, and uricacid lithiasis with or without calcium stones.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.